COVID-19 pandemic and mental health problems of adults in United States: mediating roles of cognitive concerns and behavioral changes.

Behavioral changes COVID-19 cases and deaths Cognitive concerns Generalized Anxiety Disorder (GAD) Major Depression Disorder (MDD) Mediation

Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 24 03 2021
accepted: 08 03 2022
pubmed: 30 3 2022
medline: 20 7 2022
entrez: 29 3 2022
Statut: ppublish

Résumé

We examined the associations of statewide COVID-19 conditions (i.e., state-level case and death rates) with individual-level Generalized Anxiety Disorder (GAD) and Major Depression Disorder (MDD) focusing on the salient mediating roles of individual-level cognitive concerns and behavioral changes. Using a national representative sample of adults in the United States (n = 585,073), we fitted logistic regressions to examine the overall associations between the COVID-19 pandemic and GAD/MDD. We employed a causal mediation analysis with two mediators: cognitive concerns (i.e., concerns on going to the public, loss of income, food insufficiency, housing payment, and the economy) and behavioral changes (i.e., taking fewer trips, avoiding eating-out, more online-purchase, more curbside pick-up, and cancelling doctor's appointments). We found relationships of statewide COVID-19 cases with GAD (odds ratio [OR] = 1.06; 95% confidence interval [CI] = 1.05, 1.07) and MDD (OR = 1.08; 95% CI = 1.07, 1.09). The ORs were mediated by cognitive concerns for GAD (OR = 1.02, proportion mediated: 29%) and MDD (OR = 1.01, 17%). Another salient mediator was behavioral changes for GAD (OR = 1.02, 31%) and MDD (OR = 1.01, 15%). Similar associations were found with statewide COVID-19 death. Our mediation analyses suggest that cognitive concerns and behavioral changes are important mediators of the relationships between statewide COVID-19 case/death rates and GAD/MDD. COVID-19 pandemic may involve individual-level concerns and behavior changes, and such experiences are likely to affect mental health outcomes. Public health approaches to alleviate adverse mental health consequences should take into account the mediating factors.

Identifiants

pubmed: 35348799
doi: 10.1007/s00127-022-02265-3
pii: 10.1007/s00127-022-02265-3
pmc: PMC8961082
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1557-1570

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

BMJ. 2020 May 21;369:m1904
pubmed: 32439691
Soc Psychiatry Psychiatr Epidemiol. 2021 Aug;56(8):1487-1497
pubmed: 33661353
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Epidemiology. 2013 Mar;24(2):224-32
pubmed: 23354283
JAMA. 2020 May 26;323(20):2011-2012
pubmed: 32202611
Am J Infect Control. 2020 Aug;48(8):958-960
pubmed: 32461066
Am J Public Health. 2014 May;104(5):860-4
pubmed: 24625141
BMC Public Health. 2020 Oct 21;20(1):1589
pubmed: 33087109
JAMA. 2020 Jul 21;324(3):227-228
pubmed: 32530457
MMWR Morb Mortal Wkly Rep. 2021 Apr 09;70(14):523-527
pubmed: 33830982
JAMA Intern Med. 2020 Jun 1;180(6):817-818
pubmed: 32275292
Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31
pubmed: 26719105
Soc Psychiatry Psychiatr Epidemiol. 2021 Jul;56(7):1221-1232
pubmed: 33386873
JAMA Netw Open. 2020 May 1;3(5):e2010185
pubmed: 32463467
Psychol Methods. 2013 Jun;18(2):137-50
pubmed: 23379553
Schizophr Bull. 2020 Jul 8;46(4):752-757
pubmed: 32343342
J Urban Health. 2021 Feb;98(1):13-26
pubmed: 33420551
Soc Psychiatry Psychiatr Epidemiol. 2022 Jun;57(6):1235-1246
pubmed: 34727203
JAMA. 2020 Jun 9;323(22):2235-2236
pubmed: 32432665
JAMA Psychiatry. 2020 Sep 1;77(9):891-892
pubmed: 32242888
Am J Public Health. 2020 Sep;110(9):1369-1370
pubmed: 32783713
Am J Epidemiol. 2010 Dec 15;172(12):1339-48
pubmed: 21036955
JAMA Pediatr. 2020 Sep 1;174(9):819-820
pubmed: 32286618
Behav Res Ther. 2009 Mar;47(3):215-23
pubmed: 19159867
BMC Public Health. 2020 Apr 28;20(1):569
pubmed: 32345298
Psychiatry Res. 2020 Nov;293:113419
pubmed: 32861098
Health Technol (Berl). 2021;11(2):425-435
pubmed: 33614391
Health Place. 2021 Mar;68:102539
pubmed: 33639446
Lancet Psychiatry. 2021 Feb;8(2):121-129
pubmed: 33306975
Soc Psychiatry Psychiatr Epidemiol. 2021 Aug;56(8):1499-1508
pubmed: 33590313
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057
pubmed: 32790653
Soc Psychiatry Psychiatr Epidemiol. 2020 Aug;55(8):969-971
pubmed: 32556376
Am J Public Health. 2009 May;99(5):847-54
pubmed: 18703446
Soc Psychiatry Psychiatr Epidemiol. 2022 Feb;57(2):239-243
pubmed: 34773141
JAMA Psychiatry. 2021 Jan 1;78(1):110-112
pubmed: 32725176
Int J Cogn Ther. 2022;15(1):1-19
pubmed: 34630822
Am J Epidemiol. 2020 Nov 2;189(11):1275-1277
pubmed: 32696066
Soc Psychiatry Psychiatr Epidemiol. 2022 Jun;57(6):1247-1260
pubmed: 34913985
J Anxiety Disord. 2020 Aug;74:102258
pubmed: 32569905
Demography. 2017 Oct;54(5):1653-1676
pubmed: 28755275
Soc Psychiatry Psychiatr Epidemiol. 2020 Aug;55(8):965-968
pubmed: 32472197
Am J Epidemiol. 2020 Nov 2;189(11):1232-1237
pubmed: 32666083
Ann Fam Med. 2010 Jul-Aug;8(4):348-53
pubmed: 20644190
JAMA Psychiatry. 2021 Feb 1;78(2):123-124
pubmed: 32667662
Soc Psychiatry Psychiatr Epidemiol. 2021 Aug;56(8):1447-1457
pubmed: 33665680
Lancet. 2020 Jun 20;395(10241):1897-1898
pubmed: 32450108
Am J Emerg Med. 2021 Aug;46:661-663
pubmed: 32829992
Soc Psychiatry Psychiatr Epidemiol. 2021 Dec;56(12):2275-2286
pubmed: 33616693
JAMA Netw Open. 2020 Jul 1;3(7):e2014053
pubmed: 32609353
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
J Pers Soc Psychol. 2000 Nov;79(5):837-52
pubmed: 11079245
Am J Health Promot. 2020 Jul;34(6):687-689
pubmed: 32551932
Sci Rep. 2021 Sep 14;11(1):18273
pubmed: 34521876
Soc Psychiatry Psychiatr Epidemiol. 2021 Aug;56(8):1459-1468
pubmed: 33569650
Soc Psychiatry Psychiatr Epidemiol. 2021 Dec;56(12):2287-2297
pubmed: 34003305
Expert Rev Neurother. 2012 Aug;12(8):937-47
pubmed: 23002938
JAMA Psychiatry. 2021 Jan 1;78(1):9-10
pubmed: 32579160
Soc Psychiatry Psychiatr Epidemiol. 2022 Jan;57(1):37-46
pubmed: 34282488
Am J Public Health. 2020 Jan;110(S1):S160-S166
pubmed: 31967888

Auteurs

JungHo Park (J)

SURE Education Research Group, Department of Smart City, Chung-Ang University, Seoul, South Korea.
Department of Urban Planning and Spatial Analysis, Sol Price School of Public Policy, University of Southern California, Los Angeles, CA, USA.

Jin Choi (J)

Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA.

Byoungjun Kim (B)

Department of Population Health, NYU Grossman School of Medicine, 180 Madison Ave 5th Floor, New York, NY, 10010, USA. Byoungjun.Kim@nyulangone.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH